Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy
NCT02295488Completed
- Sponsor
- Rouen University Hospital
- Start
- Mar 2015
- Primary completion
- Apr 2018
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Open-label, single-arm trial of Alyostal in Hymenoptera venom allergy (HVA), sponsored by Rouen University Hospital. Primary endpoint: Evolution of basophil activation test value. Started Mar 2015; status: completed.
02
Drugs
Alyostal
03
Conditions
Hymenoptera venom allergy (HVA)
Beyond the preview
Go deeper on NCT02295488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02295488.